Sven Haller Haller, Nguyen, Rodriguez, Emch, Gold, Bartsch, Lovblad, Giannakopoulos.

Slides:



Advertisements
Similar presentations
Corpus Callosum Damage Predicts Disability Progression and Cognitive Dysfunction in Primary-Progressive MS After Five Years.
Advertisements

DTI-Based White Matter Fiber Analysis and Visualization Jun Zhang, Ph.D. Laboratory for Computational Medical Imaging & Data Analysis Laboratory for High.
Mild Cognitive Impairment as a Target for Drug Development Steven H. Ferris, Ph.D. Silberstein Aging and Dementia Research Center New York University School.
Brain Changes in 676 ADNI subjects: Summary of 10 Studies using Tensor Based Morphometry & Automated Hippocampal Maps Paul Thompson and the UCLA ADNI.
Alzheimer’s Disease and Biomarkers John H. Dougherty,Jr.M.D. Medical Director Cole Neuroscience Center.
Dementia Research Group MRI, rates of atrophy and Alzheimer’s disease Nick Fox Dementia Research Group Institute of Neurology, UCL Queen Square, London.
COST CM1103 Training School Structure-based drug design for diagnosis and treatment of neurological diseases Istanbul, 9-13 Sept 2013 Mirjana Babić, mag.biol.mol.
ASNR 2015 Poster# EP-19 Effect of Chemotherapy on Brain Structure and Cognition in Older Women with Breast Cancer: a Brain MRI Study 1 Bihong T. Chen MD.
The Worldwide Epidemic of Senile Dementias- Challenges of Pre-Clinical Treatment Evolving Diagnostic Approaches Dimitrios Kapogiannis AAAS 2015 Annual.
Laurence Lacoste Ph. D, Paris, France 1*. Introduction : Why ?  Population’s Ageing is a Public Health issue and dementia for the Elderly a reality 
MRI as a Potential Surrogate Marker in the ADCS MCI Trial
References: [1]S.M. Smith et al. (2004) Advances in functional and structural MR image analysis and implementation in FSL. Neuroimage 23: [2]S.M.
Brain Atrophy in Type 2 Diabetes Regional distribution and influence on cognition Featured Article: Chris Moran, M.B., B.C.H., Thanh G. Phan, P.H.D., Jian.
Medical Image SBIA.UPenn Christos Davatzikos Director, Section of Biomedical Image Analysis Professor, Radiology,
Wei Chen CCNI Journal Club Alzheimer’s disease (AD): imaging & cognition imaging & cognition.
Is It Alzheimer’s? The Latest Update on Optimal Evaluation and Treatment of Patients with Memory Loss Majid Fotuhi, MD PhD March 5, 2014.
EP Visualization of Perivascular Spaces on 3T MR Images of Alzheimer Patients: University Hospital-based Dementia Cohort Study Toshinori Hirai.
Understanding Mild Cognitive Impairment. Objectives Understand the concept of MCI Identify risk factors for progression to dementia Review clinical trial.
Microstructural White Matter Abnormalities and Cognitive Functioning in Type 2 Diabetes A Diffusion Tensor Imaging Study Featured Article: Yael D. Reijmer,
conflicts of interest to report.
PharmaCog WP5 / E-ADNI. Enrollment and follow-ups Clinical sites Maximum Minimum PATIENTS EXPECTED.
High resolution MRI at 21.1 T of the hippocampus and temporal lobe white matter in the differential classification of Alzheimer’s Disease & Diffuse Lewy.
Structural MRI as a Biomarker of Disease Progression in AD Department of Diagnostic Radiology and MRI Research Lab Presented by Clifford Jack, M.D. at.
Apolipoprotein E and Gray Matter Loss in Mild Cognitive Impairment and Alzheimer’s Disease Spampinato MV, Goldsberry G, Mintzer J, Rumboldt Z Medical University.
Structural and Functional Neuroimaging in the Diagnosis of Dementia John M. Ringman, M.D. Assistant Professor UCLA Department of Neurology.
Advanced brain imaging and neurodegenerative disorders. Dott.ssa Ingrid Inches.
Adeline SL Ng, Amanda RJ Ng, Ivane Chew, Nagaendran Kandiah Department of Neurology, National Neuroscience Institute, Singapore APOE4 status modulates.
Sint Lucas-Andreas Hospital, Amsterdam
CASES SERIES BRAIN FDG PET SCAN IN DEMENTIA PATIENTS
INFLUENCE OF FRACTIONAL ANISOTROPY THRESHOLD FOR TRACT BASED DIFFUSION TENSOR ANALYSIS OF UNCINATE FASCICLES IN ALZHEIMER DISEASE Toshiaki Taoka, Toshiaki.
Medical Image Processing Alessandra Retico Istituto Nazionale di Fisica Nucleare - Sezione di Pisa Image Processing Meeting.
Rosa Maria Moresco University of Milan Bicocca
Manuela Tondelli, Gordon K. Wilcock, Paolo Nichelli, Celeste A
Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Fig. 11. Algorithm for differential diagnosis of cognitive impaired subjects by employing structural imaging. AD = Alzheimer's disease, BG = basal ganglia,
Thinner temporal and parietal cortex is related to incident clinical progression to dementia in patients with subjective cognitive decline  Sander C.J.
Volume 2, Issue 1, Pages (January 2016)
Imaging AD Progression Amyloid Imaging Agents.
Intercalating medical student – Newcastle University
Figure 1 Hypothetical staging model of sporadic Alzheimer disease (AD)
Figure 2 Overview of risk factors for Parkinson disease dementia
Early Dementia Distinguishing AD From MCI
Reisa Sperling, Elizabeth Mormino, Keith Johnson  Neuron 
Volume 10, Issue 3, Pages (January 2015)
Nat. Rev. Neurol. doi: /nrneurol
Memory and Executive Function in Aging and AD
Figure 1 Coronal MRI images showing the evolution of white matter abnormality and atrophy of patient 1 Coronal MRI images showing the evolution of white.
Probing the Biology of Alzheimer's Disease in Mice
Michael Ewers, Reisa A. Sperling, William E. Klunk, Michael W
Nat. Rev. Neurol. doi: /nrneurol
Figure 1 Cerebral MRI during the disease course Cerebral MRI with multiple cerebral supratentorial lesions during the disease course: periventricular lesions.
NEUROIMAGING FINDINGS OF RARE NEURODEGENERATIVE DISEASES RELATED TO DEMENTIA SYMPTOMS INTRODUCTION: Neurodegenerative diseases are diversified group of.
The MR scan of brain of our case vignette patient showing significant occipital lobe atrophy (especially left sided) with parietal lobe involvement as.
MRI scans show coronal sections of the brain and right hippocampus at baseline, 9 months, 2 years (when he was diagnosed with mild cognitive impairment)
Baseline Characteristics of the Subjects
Figure 2 A case of early-onset PSD
VBM results for differences in WM volume between patients with POAG and disease-free control subjects. VBM results for differences in WM volume between.
GREY MATTER CONNECTIVITY IS ASSOCIATED WITH CLINICAL PROGRESSION IN NON-DEMENTED, AMYLOID POSITIVE PATIENTS  Betty M. Tijms, Mara ten Kate, Sander C.J.
Figure 1 NMF in ADD patients and classification of prodromal Alzheimer’s disease participants. Grey matter ... Figure 1 NMF in ADD patients and classification.
Sample MR images obtained acutely from patients 1 to 6: axial T2 weighted (DWI in case 4) on the left, coronal FLAIR on the right of each panel. Sample.
Examples of the visual rating scale for the medial and lateral temporal lobe on MR coronal images displayed conventionally with the letter on the right.
A comparison of coronal T1 MRI scans showing relative atrophy within the hippocampus/temporal lobe in an AD subject (left) compared with a DLB subject.
(A) High intensity lesions in the left dorsolateral midbrain on T2 weighted magnetic resonance imaging in case 1. (A) High intensity lesions in the left.
[123I]-FP-CIT (DaTSCAN) images demonstrating: (top left) normal tracer uptake in the putamen and caudate nuclei; then progressively decreasing uptake in.
Fig. 1. ROC curve for K-IADL to diagnose dementia or MCI
Clusters of reduced grey matter concentration in the medial temporal region in patients with Alzheimer’s disease (n = 9) relative to healthy controls (n.
ROC curve for the TYM-MCI, ACE-R and MMSE in the separation of patients with aMCI/AD from those with SMC. ACE-R, Addenbrooke’s Cognitive Examinations;
Atrophied Brain T2 Lesion Volume at MRI Is Associated with Disability Progression and Conversion to Secondary Progressive Multiple Sclerosis The rate.
Box plot showing the distribution of the TYM-MCI score for patients with SMC and aMCI/AD. aMCI/AD, amnestic mild cognitive impairment or Alzheimer’s disease;
Presentation transcript:

Sven Haller Haller, Nguyen, Rodriguez, Emch, Gold, Bartsch, Lovblad, Giannakopoulos

Alzheimer Disease Coronal MRI scan shows absence (left) and presence (right) of atrophy of the medial temporal lobe in a healthy elderly subject and a patient with AD van der Flier W M and Scheltens P (2005) Use of laboratory and imaging investigations in dementia. J Neurol Neurosurg Psychiatry v45-52

VBM in MCI VBM: 11 MCI versus 10 controls

VBM: individual patient ?

MCI: stable or progressive?

a c b SVM: basics

SVM: Classification of AD Kloppel S, Stonnington C M, Chu C et al (2008) Automatic classification of MR scans in Alzheimer's disease. Brain Pt 3:

Methods 35 Controls 67 MCI Neuropsy follow-up after 1 year  40 stable MCI  27 progressive MCI MRI at baseline  DTI  SWI  other (T2w….)

Sven Haller

TBSS

Results: DTI Haller, S., Nguyen, D., Rodriguez, C., Emch, J., Gold, G., Bartsch, A. J. et al. (epub). Individual prediction of cognitive decline in mild cognitive impairment using support vector machine-based analysis of diffusion tensor imaging data. J Alzheimers Dis.

Results: DTI Haller, S., Nguyen, D., Rodriguez, C., Emch, J., Gold, G., Bartsch, A. J. et al. (epub). Individual prediction of cognitive decline in mild cognitive impairment using support vector machine-based analysis of diffusion tensor imaging data. J Alzheimers Dis.

Sven Haller

Magnitude imagePhase mask image SWI image × = SWI: basics

GRE T2* HEMO SWI

Results: SWI Haller, S., Bartsch, A. J., Nguyen, D., Rodriguez, C., Emch, J., Gold, G. et al. (in press). Susceptibility weighted imaging (SWI) assessment of cerebral microbleeds and iron deposition in mild cognitive impairment. Radiology.

Results: SWI Haller, S., Bartsch, A. J., Nguyen, D., Rodriguez, C., Emch, J., Gold, G. et al. (in press). Susceptibility weighted imaging (SWI) assessment of cerebral microbleeds and iron deposition in mild cognitive impairment. Radiology.

Conclusions SVM classification sMCI versus pMCI  at baseline MRI  98% based on DTI  84% based on SWI Higher number of microbleeds for MCI vs HC  but no difference between sMCI and pMCI Iron accumulation  MCI increased iron in the right pallidum and right substantia nigra,  MCI decreased iron in the right red nucleus

THANK YOU! The End